CRIM1 and cancer: Combined with the results of previous studies implicating the indirect interaction of the cytoplasmic domain of CRIM1 with β-catenin during nervous system development [41], it may be inferred that CRIM may impede Wnt signaling by binding to β-catenin during cancer progression.